SUPG Supergen, Inc. (MM)

SuperGen Inc. Announces Intent to Withdraw the Registration Statement for Public Offering of Shares of Common Stock DUBLIN, Calif., Feb. 23 /PRNewswire-FirstCall/ -- SuperGen Inc. announced today that it has notified the Securities and Exchange Commission of its intent to withdraw the proposed offering of shares of its common stock. In the offering, the Company had proposed to sell 9,500,000 shares and 250,000 shares of a selling stockholder. The underwriters were William Blair & Company, LLC, Needham & Company, Inc. and Rodman & Renshaw, LLC. Management will provide additional updates on the status of the business during the financial results conference call that will be held later this week. Based in Dublin, California, SuperGen is a pharmaceutical company dedicated to the acquisition, rapid development and commercialization of therapies for solid tumors, hematological malignancies and blood disorders. The Company's website can be reached at http://www.supergen.com/ . DATASOURCE: SuperGen Inc. CONTACT: Tim Enns, Vice President, Investor Relations & Business Development of SuperGen, Inc., 1-800-353-1075, ext. 111 Web site: http://www.supergen.com/

Copyright